Liver Transplant Patient Outcomes with TEG-Guided Platelet Transfusion

A retrospective cohort study of 231 patients undergoing liver transplantation between January 2019 and December 2023. It compares platelet usage and quality of life outcomes between patients receiving TEG-guided transfusions and those managed with conventional platelet count thresholds.

Use Cases

• Compare platelet transfusion rates on postoperative days 1 and 3 between the TEG and CPCT patient groups.
• Analyze the relationship between TEG MA values and postoperative quality of life scores from the SF-36 survey.
• Assess patient outcomes like mortality and major complications across different transfusion strategy cohorts.

Strengths

• Study includes 231 patient records, providing a substantive cohort for analysis.
• Data covers a 5-year time range from 2019 to 2023.
• Propensity score matching was employed to control for potential confounders, strengthening comparative analysis.

Limitations

• The dataset is small in file size (12.9 KB), suggesting limited raw data or a summary format.
• As a retrospective study, it may contain inherent selection biases not fully addressed by matching.
• The primary data format is a DOCX document, which may require extraction for structured analysis.

Provenance

Source

figshare

Collection Method

Retrospective cohort study analyzing medical records.

Time Range

January 2019 to December 2023

Freshness

Last updated in March 2026.